Laboratorios Farmaceuticos Rovi, S.A. will propose to the General Shareholders' Meeting a dividend of EUR 1.2938 per share charged to the 2022 profit and retained earnings. This proposed dividend would mean an increase of 35% on the dividend charge to the 2021 profit and represents the same 35% of the net profit for 2022 attributed to the parent company.
Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
90.05 EUR | +1.35% | 89.48 | -0.64% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.58% | 4.99B | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- Laboratorios Farmaceuticos Rovi, S.A. Proposes Dividend for the Year 2022